EMCDDA Home
  • EN
Search

Legal responses to new synthetic drugs 2000-2004 (26/10/2004)

Written to contribute to the European Commission's Communication on evaluation of the EU Action Plan, this paper highlights evidence of legislative activity related to new synthetic drugs as an indicator of Member States’ commitment to the issue. It also examines to what extent legal activity may be attributed to the EU action plan on drugs. Among others, the paper describes the wide variety of procedures that individual Member States are obliged to follow in order to control a new substance. These vary greatly between countries with the result that some simply cannot react as fast as others. This, in turn, may weaken the rationale of a fast, pan-European response to new synthetic drugs, and the effectiveness of the 1997 Joint action.

Legal responses to new synthetic drugs 2000-2004
Download this attachment in PDF format

Page last updated: Monday, 27 June 2005